Foamix于2003年1月19号在以色列成立。该公司是一家临床阶段制药公司专注于开发和商业化公司专有的泡沫米诺环素治疗痤疮,脓疱疮等皮肤状况。该公司的主导候选产品,fmx101为中度至重...查看全文
牛唐2018-07-28 22:07
$Foamix(FOMX)$ FMX101是外用的minocyline,用于治疗痤疮,预计今年下半年或明年上半年申报NDA,如果获批的话,将是首个获批的米诺环素外用药查看全文
$Foamix(FOMX)$ 8-K - Current report Filed: 2019-09-20 AccNo: 0001178913-19-002378 Size: 46 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Foamix(FOMX)$ 内部交易: 2019-09-10,CFO & Country Manager,Hadar Ilan ,卖出,34392普通股, $3.50
$Foamix(FOMX)$ 内部交易: 2019-09-09,CFO & Country Manager,Hadar Ilan ,卖出,9420普通股, $3.50
$Foamix(FOMX)$ 8-K - Current report Filed: 2019-09-04 AccNo: 0001178913-19-002310 Size: 29 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Foamix(FOMX)$ 内部交易: 2019-08-26,Director,KAZANCHYAN ANNA ,卖出,7049普通股, $3.27
$Foamix(FOMX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-08-19 AccNo: 0001178913-19-002219 Size: 515 KB 网页链接
$Foamix(FOMX)$ 8-K - Current report Filed: 2019-08-19 AccNo: 0001178913-19-002221 Size: 394 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Foamix(FOMX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-08-15 AccNo: 0001193125-19-222574 Size: 106 KB 网页链接
$Foamix(FOMX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-07 AccNo: 0001178913-19-002091 Size: 4 MB 网页链接
$Foamix(FOMX)$ 8-K - Current report Filed: 2019-08-07 AccNo: 0001178913-19-002089 Size: 184 KBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接